The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4'-((4-Chloro-2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carboxamide ID: ALA4527674
PubChem CID: 155544248
Max Phase: Preclinical
Molecular Formula: C24H22ClN3O
Molecular Weight: 403.91
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1nc2c(Cl)cccc2n1Cc1ccc(-c2ccccc2C(N)=O)cc1
Standard InChI: InChI=1S/C24H22ClN3O/c1-2-6-22-27-23-20(25)9-5-10-21(23)28(22)15-16-11-13-17(14-12-16)18-7-3-4-8-19(18)24(26)29/h3-5,7-14H,2,6,15H2,1H3,(H2,26,29)
Standard InChI Key: BVEXQGDXQBHFFA-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
20.8204 -2.7074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8193 -3.5311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5315 -3.9401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5297 -2.2944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2383 -2.7038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2386 -3.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0214 -3.7793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5065 -3.1127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0209 -2.4507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0134 -4.5977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7213 -5.0173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7085 -5.8369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4155 -6.2523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1322 -5.8505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1376 -5.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4300 -4.6092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8392 -6.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8310 -7.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5385 -7.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2548 -7.0951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2590 -6.2696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5509 -5.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5555 -5.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2696 -4.6288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8460 -4.6208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3278 -3.1124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7403 -2.4004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5616 -2.4001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5272 -1.4731 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
14 17 1 0
22 23 1 0
23 24 1 0
23 25 2 0
8 26 1 0
26 27 1 0
27 28 1 0
4 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.91Molecular Weight (Monoisotopic): 403.1451AlogP: 5.46#Rotatable Bonds: 6Polar Surface Area: 60.91Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.92CX LogP: 5.58CX LogD: 5.58Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -1.27
References 1. Schoepf AM, Salcher S, Obexer P, Gust R.. (2020) Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators., 185 [PMID:31648125 ] [10.1016/j.ejmech.2019.111748 ]